1. Home
  2. CNTX vs APT Comparison

CNTX vs APT Comparison

Compare CNTX & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

HOLD

Current Price

$5.14

Market Cap

53.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTX
APT
Founded
2015
1983
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
53.3M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
CNTX
APT
Price
$0.38
$5.14
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
1.7M
22.9K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
17.39
N/A
EPS
N/A
0.24
Revenue
N/A
$59,142,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.04
Revenue Growth
N/A
2.25
52 Week Low
$0.34
$4.34
52 Week High
$3.62
$7.50

Technical Indicators

Market Signals
Indicator
CNTX
APT
Relative Strength Index (RSI) 38.40 47.85
Support Level $0.34 $5.13
Resistance Level $0.70 $5.23
Average True Range (ATR) 0.02 0.14
MACD 0.01 -0.01
Stochastic Oscillator 73.14 19.89

Price Performance

Historical Comparison
CNTX
APT

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.

Share on Social Networks: